chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Pain
Clinical narrative: FAINTED; SEIZURE; STOPPED BREATHING; LIGHT HEADED; CYANOSIS; This spontaneous report received from a health care professional (public health nurse) concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 043A21A, and expiry: 31-DEC-2069) dose was not reported, 1 total, administered on left arm on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, about 5 minutes after vaccination, the patient experienced lightheadedness, then fainted, had a seizure, stopped breathing (for 10 seconds), and developed cyanosis (turned blue). The nurse did cardiopulmonary resuscitation (CPR) and the Emergency Medical Services (EMS) was called. By the time the EMS arrived, the patient felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stopped breathing on 07-APR-2021, and was recovering from light headed, fainted, seizure, and cyanosis. This report was serious (Other Medically Important Condition, and Life Threatening). This case, from the same reporter is linked to 20210417723.; Sender's Comments: v0 This report involves a female patient of unspecified age who experienced lightheadedness, then fainted, had a seizure, stopped breathing and developed cyanosis about 5 minutes after receiving Janssen COVID-19 Vaccine Ad26.COV2.S for prophylactic vaccination. Given the close temporal relationship the events are considered possibly related to the vaccination.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Dyspnoea, Heart rate, Nausea
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Neck pain, Oxygen saturation, Pharyngeal swelling, Tachycardia, Throat irritation
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Apnoea, Cold sweat, Dizziness, Rash, Seizure
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Speech disorder
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cyanosis, Dizziness, Respiratory arrest, Seizure, Syncope
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Pain
Clinical narrative: CHEST PRESSURE; DIZZINESS; BODY ACHES; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient had chest pressure, dizziness and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chest pressure, dizziness, and body aches. This report was serious (Life Threatening). This case, from the same reporter is linked to 20210414557 and 20210414564.; Sender's Comments: v0 This report involves a patient of unspecified age and gender who experienced chest pressure, dizziness and body aches the same day the Janssen COVID-19 Vaccine Ad26.COV2 had administered.  Medical history, concomitant medications, and details of the event were not reported. This case has insufficient information to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Anion gap, Aspartate aminotransferase normal, Basophil count normal
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil percentage, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium decreased
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood osmolarity, Blood potassium normal
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea nitrogen/creatinine ratio, Blood urea normal, Carbon dioxide normal, Cerebral venous sinus thrombosis
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dyspnoea, Eosinophil count normal, Eosinophil percentage, Globulin
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glomerular filtration rate, Haematocrit normal, Haemoglobin normal, Headache, Hyperhidrosis
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphocyte count increased, Lymphocyte percentage increased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean platelet volume normal, Monocyte count increased, Monocyte percentage, Neutrophil count normal, Neutrophil percentage decreased
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Platelet count normal, Protein total normal, Red blood cell count normal, Red cell distribution width normal
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast abnormal, Troponin T normal, Venogram abnormal, Vision blurred, White blood cell count normal
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she  called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81  mg  the patient left clinic and start back to work on the 19th
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Computerised tomogram, Dizziness, Full blood count, Headache
Clinical narrative: Patient was feeling chest pressure and feeling of fainting while standing. Was complaining of head ache. Called 911 and was transferred to the hospital in an ambulance.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lipase, Metabolic function test
Clinical narrative: Patient was feeling chest pressure and feeling of fainting while standing. Was complaining of head ache. Called 911 and was transferred to the hospital in an ambulance.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Headache
Clinical narrative: Patient was feeling chest pressure and feeling of fainting while standing. Was complaining of head ache. Called 911 and was transferred to the hospital in an ambulance.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Lip swelling, Pharyngeal paraesthesia
Clinical narrative: Patient reports that about 20 minutes after receiving the vaccine, she began to experience some perioral paresthesias and lip swelling sensation as well as some tongue paresthesias.  Reports that she felt as if she had a cotton ball in the back of her throat.  No rash, chest pain, shortness of breath.  No significant throat closing sensation.  Patient took one of her EpiPen's as she always carries them with her.  Reports that she took a second EpiPen about 15 minutes later.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Oropharyngeal discomfort, Paraesthesia, Paraesthesia oral
Clinical narrative: Patient reports that about 20 minutes after receiving the vaccine, she began to experience some perioral paresthesias and lip swelling sensation as well as some tongue paresthesias.  Reports that she felt as if she had a cotton ball in the back of her throat.  No rash, chest pain, shortness of breath.  No significant throat closing sensation.  Patient took one of her EpiPen's as she always carries them with her.  Reports that she took a second EpiPen about 15 minutes later.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Blood magnesium, Brain natriuretic peptide, Chest X-ray, Computerised tomogram abnormal
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Contusion, Dizziness, Electrocardiogram, Erythema
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Hemiparesis, Loss of consciousness, Magnetic resonance imaging head, Magnetic resonance imaging head abnormal
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic function test, Nausea, Petechiae, Platelet count decreased, Postictal state
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Prothrombin time, Retching, Seizure, Troponin
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram normal, Condition aggravated, Full blood count abnormal, Magnetic resonance imaging normal, Nausea
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Seizure, Thrombocytopenia, Unresponsive to stimuli
Clinical narrative: 53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021.  10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER.  CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Mobility decreased, Pain, Pain in extremity, Sleep disorder
Clinical narrative: After COVID-19 vaccine, patient felt the vaccine was given too high and felt different, hot tingling sensation. Arm started hurting by the evening, had limited ability to move it for 48 hours. Since then (4/8/21) went to Urgent Care. They state injection site was odd and too high. Less than a finger width from bone. Having an MRI/CT scan this week (week of 4/19/21). Not sleeping at night due to arm pain.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Mobility decreased, Pain in extremity, Paraesthesia, Sleep disorder
Clinical narrative: After COVID-19 vaccine, patient felt the vaccine was given too high and felt different, hot tingling sensation. Arm started hurting by the evening, had limited ability to move it for 48 hours. Since then (4/8/21) went to Urgent Care. They state injection site was odd and too high. Less than a finger width from bone. Having an MRI/CT scan this week (week of 4/19/21). Not sleeping at night due to arm pain.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient brought in by rescue squad reportedly after allergic reaction to of Pfizer COVID vaccine 1st dose.  Rescue squad gave her a dose of Solu-Medrol IV and an IM shot of Benadryl 50 mg. Patient reports that she initially became very itchy she still remains very itchy she thought she had some tingling or may be slight swelling her lips and felt like she was having some problems breathing but admits she is very anxious because of her extensive allergy issues.  Here she is clearly very pruritic and slightly flushed.  But is breathing easily speaking in full complete sentences.  She has no other acute complaints.  Symptoms started within minutes after receiving immunization.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Anxiety, Condition aggravated, Dyspnoea, Flushing
Clinical narrative: Patient brought in by rescue squad reportedly after allergic reaction to of Pfizer COVID vaccine 1st dose.  Rescue squad gave her a dose of Solu-Medrol IV and an IM shot of Benadryl 50 mg. Patient reports that she initially became very itchy she still remains very itchy she thought she had some tingling or may be slight swelling her lips and felt like she was having some problems breathing but admits she is very anxious because of her extensive allergy issues.  Here she is clearly very pruritic and slightly flushed.  But is breathing easily speaking in full complete sentences.  She has no other acute complaints.  Symptoms started within minutes after receiving immunization.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Lip swelling, Paraesthesia oral, Pruritus, Rash pruritic
Clinical narrative: Patient brought in by rescue squad reportedly after allergic reaction to of Pfizer COVID vaccine 1st dose.  Rescue squad gave her a dose of Solu-Medrol IV and an IM shot of Benadryl 50 mg. Patient reports that she initially became very itchy she still remains very itchy she thought she had some tingling or may be slight swelling her lips and felt like she was having some problems breathing but admits she is very anxious because of her extensive allergy issues.  Here she is clearly very pruritic and slightly flushed.  But is breathing easily speaking in full complete sentences.  She has no other acute complaints.  Symptoms started within minutes after receiving immunization.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Patient brought in by rescue squad reportedly after allergic reaction to of Pfizer COVID vaccine 1st dose.  Rescue squad gave her a dose of Solu-Medrol IV and an IM shot of Benadryl 50 mg. Patient reports that she initially became very itchy she still remains very itchy she thought she had some tingling or may be slight swelling her lips and felt like she was having some problems breathing but admits she is very anxious because of her extensive allergy issues.  Here she is clearly very pruritic and slightly flushed.  But is breathing easily speaking in full complete sentences.  She has no other acute complaints.  Symptoms started within minutes after receiving immunization.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint swelling, Peripheral swelling, Ultrasound Doppler
Clinical narrative: Pt noticed his calf was swollen and had some pain/tenderness on Wednesday. He then went back to the clinic on Friday where they instructed him to report to the ER. At the ER he was diagnosed with a DVT and told to begin Eliquis that night.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Pain in extremity, Peripheral swelling, Tenderness
Clinical narrative: Pt noticed his calf was swollen and had some pain/tenderness on Wednesday. He then went back to the clinic on Friday where they instructed him to report to the ER. At the ER he was diagnosed with a DVT and told to begin Eliquis that night.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Cardiovascular evaluation, Computerised tomogram, Headache, Pulmonary thrombosis
Clinical narrative: On 4/12 pt developed a headache then on 4/15 pt became short of breath with severe chest pain. pt was admitted to hospital and had a pulmonary emboli in his left lower lobe. He was sent on home on anticoagulant therapy after 2 days
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram, Pulmonary embolism
Clinical narrative: On 4/12 pt developed a headache then on 4/15 pt became short of breath with severe chest pain. pt was admitted to hospital and had a pulmonary emboli in his left lower lobe. He was sent on home on anticoagulant therapy after 2 days
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Chest X-ray abnormal, Chest pain, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: On 4/12 pt developed a headache then on 4/15 pt became short of breath with severe chest pain. pt was admitted to hospital and had a pulmonary emboli in his left lower lobe. He was sent on home on anticoagulant therapy after 2 days
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Headache, Laboratory test, Pulmonary embolism, Scan with contrast abnormal
Clinical narrative: On 4/12 pt developed a headache then on 4/15 pt became short of breath with severe chest pain. pt was admitted to hospital and had a pulmonary emboli in his left lower lobe. He was sent on home on anticoagulant therapy after 2 days
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ultrasound Doppler
Clinical narrative: On 4/12 pt developed a headache then on 4/15 pt became short of breath with severe chest pain. pt was admitted to hospital and had a pulmonary emboli in his left lower lobe. He was sent on home on anticoagulant therapy after 2 days
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Antiphospholipid antibodies, C-reactive protein increased, Contusion, Gingival bleeding, Immune thrombocytopenia
Clinical narrative: Patient is a 46-year-old woman who presents emergency department by private vehicle for concerns of low platelets.  Over the past few weeks she has had bruising and petechia, and today was noted to have platelets of 17. Additionally, she has noted bleeding gums, and today has had a severe headache.  Her headache is described as posterior and right-sided.  Her husband, a former emergency physician, states that she also has been mildly confused.  She has a history of Behcet's and is on Otezla.  She also recently received the 2nd dose of Moderna vaccine.  She noticed increased bruising while on vacation.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunoglobulin therapy, Petechiae, Platelet count decreased, Platelet transfusion, Thrombocytopenia
Clinical narrative: Patient is a 46-year-old woman who presents emergency department by private vehicle for concerns of low platelets.  Over the past few weeks she has had bruising and petechia, and today was noted to have platelets of 17. Additionally, she has noted bleeding gums, and today has had a severe headache.  Her headache is described as posterior and right-sided.  Her husband, a former emergency physician, states that she also has been mildly confused.  She has a history of Behcet's and is on Otezla.  She also recently received the 2nd dose of Moderna vaccine.  She noticed increased bruising while on vacation.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Antibody test negative, Confusional state, Contusion, Full blood count abnormal, Gingival bleeding
Clinical narrative: Patient is a 46-year-old woman who presents emergency department by private vehicle for concerns of low platelets.  Over the past few weeks she has had bruising and petechia, and today was noted to have platelets of 17. Additionally, she has noted bleeding gums, and today has had a severe headache.  Her headache is described as posterior and right-sided.  Her husband, a former emergency physician, states that she also has been mildly confused.  She has a history of Behcet's and is on Otezla.  She also recently received the 2nd dose of Moderna vaccine.  She noticed increased bruising while on vacation.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Immune thrombocytopenia, Immunoglobulin therapy, Petechiae, Platelet count decreased
Clinical narrative: Patient is a 46-year-old woman who presents emergency department by private vehicle for concerns of low platelets.  Over the past few weeks she has had bruising and petechia, and today was noted to have platelets of 17. Additionally, she has noted bleeding gums, and today has had a severe headache.  Her headache is described as posterior and right-sided.  Her husband, a former emergency physician, states that she also has been mildly confused.  She has a history of Behcet's and is on Otezla.  She also recently received the 2nd dose of Moderna vaccine.  She noticed increased bruising while on vacation.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet transfusion, Thrombocytopenia
Clinical narrative: Patient is a 46-year-old woman who presents emergency department by private vehicle for concerns of low platelets.  Over the past few weeks she has had bruising and petechia, and today was noted to have platelets of 17. Additionally, she has noted bleeding gums, and today has had a severe headache.  Her headache is described as posterior and right-sided.  Her husband, a former emergency physician, states that she also has been mildly confused.  She has a history of Behcet's and is on Otezla.  She also recently received the 2nd dose of Moderna vaccine.  She noticed increased bruising while on vacation.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: April 17, 2021 History of Present Illness The patient was admitted for a potential post vaccination reaction pattern.  She received the majority of vaccine 1 week ago on Saturday within 24 hours start developing a pruritic process with a cutaneous eruption on the back of her neck this progressed over 72 hours to involve the entire body area.  She does state that she felt something is in her mouth but was unclear whether they were truly ulcers.  There was no involvement of any tongue or lip swelling, nasal (sneezing, rhinorrhea), ocular (tearing, injection of eyes, tunnel vision), respiratory wheezing cough, change in voice) or gastrointestinal symptoms (nausea, vomiting or diarrhea associated with the administration of the moderna vaccine.  She does have a history of asthma as a child and through her adolescent years.  She does not have a history of asthma at the present time she does have some mild seasonal allergies she had seen an otolaryngologist in the past and told her that she had nasal allergies. The reaction consisted of a progressive cutaneous eruption that started in her neck and went to her torso and upper arms and then progressed to her lower extremities and her abdomen as well as her back and neck and face over the course of 72 hours.  The vaccination occurred on Saturday and the patient was seen by her primary care physician on Wednesday and given steroids which did not have any effect.  She then came to the emergency department on Thursday where she was admitted for a reaction pattern and has been in the hospital since.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aspartate aminotransferase increased, C-reactive protein normal, Rash, Rash pruritic, SARS-CoV-2 test positive
Clinical narrative: April 17, 2021 History of Present Illness The patient was admitted for a potential post vaccination reaction pattern.  She received the majority of vaccine 1 week ago on Saturday within 24 hours start developing a pruritic process with a cutaneous eruption on the back of her neck this progressed over 72 hours to involve the entire body area.  She does state that she felt something is in her mouth but was unclear whether they were truly ulcers.  There was no involvement of any tongue or lip swelling, nasal (sneezing, rhinorrhea), ocular (tearing, injection of eyes, tunnel vision), respiratory wheezing cough, change in voice) or gastrointestinal symptoms (nausea, vomiting or diarrhea associated with the administration of the moderna vaccine.  She does have a history of asthma as a child and through her adolescent years.  She does not have a history of asthma at the present time she does have some mild seasonal allergies she had seen an otolaryngologist in the past and told her that she had nasal allergies. The reaction consisted of a progressive cutaneous eruption that started in her neck and went to her torso and upper arms and then progressed to her lower extremities and her abdomen as well as her back and neck and face over the course of 72 hours.  The vaccination occurred on Saturday and the patient was seen by her primary care physician on Wednesday and given steroids which did not have any effect.  She then came to the emergency department on Thursday where she was admitted for a reaction pattern and has been in the hospital since.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stomatitis, White blood cell count increased
Clinical narrative: April 17, 2021 History of Present Illness The patient was admitted for a potential post vaccination reaction pattern.  She received the majority of vaccine 1 week ago on Saturday within 24 hours start developing a pruritic process with a cutaneous eruption on the back of her neck this progressed over 72 hours to involve the entire body area.  She does state that she felt something is in her mouth but was unclear whether they were truly ulcers.  There was no involvement of any tongue or lip swelling, nasal (sneezing, rhinorrhea), ocular (tearing, injection of eyes, tunnel vision), respiratory wheezing cough, change in voice) or gastrointestinal symptoms (nausea, vomiting or diarrhea associated with the administration of the moderna vaccine.  She does have a history of asthma as a child and through her adolescent years.  She does not have a history of asthma at the present time she does have some mild seasonal allergies she had seen an otolaryngologist in the past and told her that she had nasal allergies. The reaction consisted of a progressive cutaneous eruption that started in her neck and went to her torso and upper arms and then progressed to her lower extremities and her abdomen as well as her back and neck and face over the course of 72 hours.  The vaccination occurred on Saturday and the patient was seen by her primary care physician on Wednesday and given steroids which did not have any effect.  She then came to the emergency department on Thursday where she was admitted for a reaction pattern and has been in the hospital since.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral congestion, Cerebral haematoma, Cerebral haemorrhage, Cerebral mass effect, Cerebral venous sinus thrombosis
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Jugular vein thrombosis, Mastoid effusion, Musculoskeletal stiffness, Nausea
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Vasogenic cerebral oedema, Venogram abnormal, Vision blurred, Vomiting
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebral haemorrhage, Computerised tomogram head abnormal, Fibrin D dimer increased, Headache
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunoglobulin therapy, Intensive care, Jugular vein thrombosis, Magnetic resonance imaging head abnormal, Neck pain
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Superior sagittal sinus thrombosis, Thrombectomy, Transverse sinus thrombosis, Venogram abnormal
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenopia, Blood glucose increased, Blood sodium normal, Brain oedema, Breast feeding
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Fibrin D dimer increased, Haptoglobin increased, Headache, Heparin-induced thrombocytopenia test
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Nausea, Neck pain, Photophobia, Platelet count decreased
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Postpartum state, Prothrombin time shortened, Subarachnoid haemorrhage, Thrombectomy, Thrombosis
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.